Abstract | AIMS: METHODS: We studied 14,403 Atherosclerosis Risk in Communities (ARIC) study participants who were free of atherosclerotic cardiovascular disease at baseline. TC/ HDL-cholesterol discordance with LDL-cholesterol (estimated by the novel Martin/Hopkins method) and non- HDL-cholesterol was assessed at five visits and determined by being at or above the median for each lipid parameter. We constructed Cox proportional hazard models to estimate the risk for incident atherosclerotic cardiovascular disease events associated with each lipid concordance/discordance category using a time-varying approach. RESULTS: Mean age of participants was 54.1 years, 56% women and 25% black. There were 2634 atherosclerotic cardiovascular disease events over a median (interquartile range) follow-up of 24.2 (16.0-25.4) years. Among individuals with LDL-cholesterol and non- HDL-cholesterol less than the median, 26% and 21% had discordant TC/ HDL-cholesterol at or above the median, respectively. These individuals had a 24% (hazard ratio (HR) 1.24, 95% confidence interval (CI) 1.09, 1.41) and 29% (HR 1.29, 95% CI 1.13, 1.46) greater risk of incident atherosclerotic cardiovascular disease, respectively, compared to those with TC/ HDL-cholesterol less than the median after multivariable adjustment. In individuals with diabetes with LDL-cholesterol or non- HDL-cholesterol less than the median, discordant TC/ HDL-cholesterol at or above the median was more prevalent at 48% and 38%, respectively. CONCLUSION:
|
Authors | Renato Quispe, Mohamed B Elshazly, Di Zhao, Peter P Toth, Rishi Puri, Salim S Virani, Roger S Blumenthal, Seth S Martin, Steven R Jones, Erin D Michos |
Journal | European journal of preventive cardiology
(Eur J Prev Cardiol)
Vol. 27
Issue 15
Pg. 1597-1605
(10 2020)
ISSN: 2047-4881 [Electronic] England |
PMID | 31291776
(Publication Type: Journal Article, Multicenter Study, Research Support, N.I.H., Extramural)
|
Chemical References |
- Biomarkers
- Cholesterol, HDL
- Cholesterol, LDL
- Cholesterol
|
Topics |
- Atherosclerosis
(blood, epidemiology, prevention & control)
- Biomarkers
(blood)
- Cardiovascular Diseases
(blood, epidemiology, prevention & control)
- Cholesterol
(blood)
- Cholesterol, HDL
(blood)
- Cholesterol, LDL
(blood)
- Female
- Follow-Up Studies
- Humans
- Incidence
- Male
- Middle Aged
- Primary Prevention
(methods)
- Prospective Studies
- Risk Assessment
(methods)
- Risk Factors
- United States
(epidemiology)
|